Patents by Inventor Christopher John Montague Meade

Christopher John Montague Meade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for nebulizing aqueous compositions containing highly concentrated insulin
    Publication number: 20030064032
    Abstract: A process for nebulizing highly concentrated solutions of insulin for administration by inhalation.
    Type: Application
    Filed: November 6, 2002
    Publication date: April 3, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Herbert Lamche, Christopher John Montague Meade, Bernd Zierenberg, Ralph Christian Reimholz
  • Imidazotriazolopyrimidines with adenosine-antagonistic activity
    Patent number: 6492377
    Abstract: New imidazotriazolopyrimidine derivatives of the formula Preferred are those compounds wherein: R1 denotes methyl, which is optionally substituted by phenyloxy or pyrrole; or R1 denotes benzyl which is optionally substituted by hydroxy, methoxy, dimethylaminoethoxy or fluorine; or R1 denotes cyclopentyl, furan or phenylethyl; R2 or R3 denote ethyl, n-propyl, allyl or propargyl; R4 or R6 denote hydrogen; and, R5 denotes methyl, n-propyl, tert.butyl, cyclopentyl or norbornenyl. These are adenosine antagonists are are useful for, inter alia, the treatment of senile dementia of the Alzheimer's type.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: December 10, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Stefan Blech, Adrian Carter, Wolfram Gaida, Matthias Hoffmann, Ulrike Kuefner-Muehl, Christopher John Montague Meade, Gerald Pohl, Werner Kummer, Erich Lehr, Joachim Mierau, Thomas Weiser
  • Pharmaceutical compositions based on anticholinergics and corticosteroids
    Publication number: 20020183292
    Abstract: A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: October 19, 2001
    Publication date: December 5, 2002
    Inventors: Michel Pairet, Michael P. Pieper, Christopher John Montague Meade, Richard Reichl, Christel Schmelzer
  • Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
    Publication number: 20020151541
    Abstract: A pharmaceutical composition comprising a tiotropium salt; and an antihistamine, optionally together with a pharmaceutically acceptable excipient, the tiotropium salt and the antihistamine optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: October 19, 2001
    Publication date: October 17, 2002
    Inventors: Michel Pairet, Michael P. Pieper, Christopher John Montague Meade, Christel Schmelzer
  • Tricyclic nitrogen heterocycles as PDE IV inhibitors
    Patent number: 6417190
    Abstract: The invention relates to the use of tricyclic nitrogen heterocycles of general formula I as pharmaceutical compositions with an inhibitory effect on PDE IV, wherein the groups R1, R2 and R3 have the meanings given in the specification and claims.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: July 9, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Matthias Hoffmann, Birgit Jung, Ulrike Kuefner-Muehl, Christopher John Montague Meade
  • Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
    Patent number: 6288277
    Abstract: The present invention relates to new phenylamine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: September 11, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6265612
    Abstract: The present invention relates to new benzamidine derivatives, processes for preparing them and their use in pharmaceutical compositions.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: July 24, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6197824
    Abstract: Novel benzamidines, having LTB4-antagonistic activity, of the formula methods for their preparation, their and their use as medicaments.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Phenylamidine derivatives, a process for preparing the same and their use as medicaments
    Patent number: 6127423
    Abstract: The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: October 3, 2000
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade, Andreas Ding
  • Use of Epinastine for the treatment of pain
    Patent number: 5942503
    Abstract: Disclosed herein is the use of epinastine for the treatment of pain, including migraine, Bing-Horton syndrome, tension headaches, muscle pain, inflammatory pain, and neuralgias. Epinastine may also be administered in combination with an additional analgesic for treating pain.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: August 24, 1999
    Assignee: Boehringer Indelheim KG
    Inventors: Birgit Jung, Christopher John Montague Meade, Michel Pairet